Special Issue "New Insights into Transporters in Drug Development"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".

Deadline for manuscript submissions: 30 November 2023 | Viewed by 196

Special Issue Editors

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA
Interests: pharmacogenomics; membrane transporters; orphan transporter
Department of Drug Metabolism and Pharmacokinetics (DMPK), Bristol Myers Squibb, Princeton, NJ, USA
Interests: transporter biomarkers; drug transporters; pharmacokinetics

Special Issue Information

Dear Colleagues,

You're invited to submit an article for a Special Issue on “New Insights into Transporters in Drug Development”. As a respected leader in this field, your expertise would make a valuable contribution to this Special Issue.

The Special Issue aims to highlight the recent advances in the research on transporters and their role in drug development. Original research articles, reviews, and perspectives are welcome on topics including, but not limited to, the following:

  • Endogenous biomarkers for drug transporters;
  • Transporter proteomics-based in vitro-to-in vivo extrapolation;
  • Physiologically-based pharmacokinetic models for predicting transporter-mediated drug interactions;
  • Computational and experimental approaches to identify transporter ligands, substrates, and inhibitors;
  • Resources and tools relevant to transporters in drug development;
  • Clinical implications of transporter-mediated drug disposition and response.

The deadline for submissions is November 30, 2023, and the Special Issue will be published in Pharmaceutics later this year. Your contribution to this important topic is eagerly anticipated.


Dr. Sook Wah Yee
Dr. Hong Shen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • membrane transporters
  • drug–drug interactions
  • in vitro-to-in vivo extrapolation
  • transporters as therapeutic targets
  • regulation of transporter expression and activity

Published Papers

This special issue is now open for submission.
Back to TopTop